华邦健康(002004) - 2019 Q1 - 季度财报

Financial Performance - The company's operating revenue for Q1 2019 was ¥2,453,145,195.80, a decrease of 9.39% compared to ¥2,697,358,960.72 in the same period last year[9] - Net profit attributable to shareholders was ¥100,028,288.20, representing an increase of 3.63% from ¥96,080,842.50 in the previous year[9] - The company reported a total of 103,049 common shareholders at the end of the reporting period[13] - The company reported a net cash flow from operating activities of ¥126,435,744.62, a significant increase of 421.07% compared to the previous year[24] - The total profit (loss) for the current period was -¥31,617,729.63, worsening from -¥10,065,013.36 in the previous period[71] - The net profit (loss) attributable to continuous operations was -¥31,617,729.63, compared to -¥6,358,336.74 in the previous period, showing a significant increase in losses[73] - The total revenue for the current period was approximately ¥2,198,968,866.01, a decrease from ¥2,312,358,296.02 in the previous period, reflecting a decline of about 4.9%[74] Cash Flow - The net cash flow from operating activities improved significantly to ¥126,435,744.62, a 421.07% increase from a negative cash flow of ¥45,294,248.61 in the same period last year[9] - The cash flow from investing activities resulted in a net outflow of -¥177,190,746.40, an improvement from -¥245,308,946.07 in the previous period[80] - The cash flow from financing activities generated a net inflow of ¥471,809,739.79, compared to a net outflow of -¥592,137,946.67 in the previous period, indicating a positive shift[80] - The company’s cash flow from operating activities showed a net inflow of CNY 135,939,588.96, compared to CNY 147,079,410.77 in the previous period[66] - The net cash flow from financing activities was $285,470,770.96, a significant recovery from -$593,559,687.47 in the prior year[88] Assets and Liabilities - Total assets at the end of the reporting period were ¥27,175,098,117.00, reflecting a 1.99% increase from ¥26,551,501,975.89 at the end of the previous year[9] - Total current assets amounted to $11,275,275,972.45, an increase from $11,002,558,531.97[42] - Total non-current assets reached $15,899,822,144.55, up from $15,641,864,016.93[42] - Total liabilities increased to CNY 7,249,700,217.29 from CNY 6,953,457,631.54, representing an increase of 4.26%[58] - Total liabilities amounted to ¥13,894,523,484.92, with non-current liabilities at ¥3,151,441,875.95[96] - The company’s total liabilities decreased significantly, with a notable reduction in employee compensation payable by ¥125,210,771.65, or 55.97%[24] Shareholder Information - The largest shareholder, Tibet Huibang Technology Co., Ltd., held 14.27% of the shares, totaling 290,449,804 shares[13] - The company repurchased a total of 54,908,494 shares, representing 2.6984% of the total share capital, at a total cost of ¥275,676,260.71[28] Government Subsidies and Other Income - The company received government subsidies amounting to ¥9,023,975.51 during the reporting period[11] - The company’s other income increased by ¥2,505,533.49, or 30.09%, mainly due to government subsidies received[24] - The company reported a non-operating income of ¥9,618,341.35 after accounting for various non-recurring items[11] Financial Standards and Reporting - The company executed new financial accounting standards starting January 1, 2019, impacting the classification of financial assets[96] - The first quarter report was not audited, indicating preliminary financial data[103]